The governor also said she would work with other states to leverage their combined purchasing power to reduce the cost of the ...

Drugs like Ozempic, Wegovy and Mounjaro are changing the game for weight loss. GLP-1 medications were originally intended to ...

Ozempic doesn't just reduce weight. Research shows GLP-1s also changes how much people spend on food, and the types of food ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Ozempic and Wegovy have become popular options for people looking to lose weight, but there are some risks and side effects ...

Novo Nordisk's shares plummeted due to disappointing trial results for CagriSema, with patients achieving only 22.7% weight ...

The weight-loss succession race is heating up. Here's how biopharma execs talked up those efforts at JPM this week.